Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Asensus Surgical Inc (ASXC)
Asensus Surgical Inc (ASXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,652
  • Shares Outstanding, K 264,317
  • Annual Sales, $ 7,090 K
  • Annual Income, $ -75,560 K
  • 60-Month Beta 1.43
  • Price/Sales 12.55
  • Price/Cash Flow N/A
  • Price/Book 1.69
Trade ASXC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.31
  • Most Recent Earnings $-0.06 on 11/14/23
  • Latest Earnings Date 03/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 721.25% ( -1.99%)
  • Historical Volatility 49.80%
  • IV Percentile 81%
  • IV Rank 52.80%
  • IV High 1,290.90% on 03/14/23
  • IV Low 84.11% on 11/16/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 99
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,436
  • Open Int (30-Day) 1,126

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2500 +13.64%
on 02/07/24
0.3200 -11.22%
on 02/15/24
-0.0170 (-5.65%)
since 01/22/24
3-Month
0.2280 +24.61%
on 11/24/23
0.3801 -25.26%
on 12/27/23
+0.0442 (+18.42%)
since 11/22/23
52-Week
0.2040 +39.26%
on 10/30/23
0.9564 -70.29%
on 02/23/23
-0.5998 (-67.86%)
since 02/22/23

Most Recent Stories

More News
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics

Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics

QNRX : 2.73 (-4.47%)
ASXC : 0.2868 (-1.10%)
Asensus Shares First Quarter Results and Future Plans

Asensus Shares First Quarter Results and Future Plans

QNRX : 2.73 (-4.47%)
ASXC : 0.2868 (-1.10%)
DexCom (DXCM) Q1 Earnings and Revenues Beat Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 13.33% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DXCM : 115.48 (-0.78%)
ASXC : 0.2868 (-1.10%)
Asensus Surgical (ASXC) Reports Q4 Loss, Lags Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 1.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ASXC : 0.2868 (-1.10%)
AWH : 4.63 (-0.64%)
Asensus Surgical (ASXC) Reports Q3 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 25.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ASXC : 0.2868 (-1.10%)
VERU : 0.4760 (-4.42%)
Globus Medical (GMED) Q3 Earnings Lag Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of -3.85% and 0.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

GMED : 55.68 (+1.24%)
ASXC : 0.2868 (-1.10%)
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 8.57% and 8.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PACB : 5.19 (+2.17%)
ASXC : 0.2868 (-1.10%)
AxoGen (AXGN) Soars 8.6%: Is Further Upside Left in the Stock?

AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

AXGN : 10.39 (-0.10%)
ASXC : 0.2868 (-1.10%)
Zacks Industry Outlook Highlights ShockWave Medical, Semler Scientific and Asensus Surgical

ShockWave Medical, Semler Scientific and Asensus Surgical are part of Zacks Industry Outlook article.

SMLR : 47.96 (+4.15%)
SWAV : 269.80 (+4.32%)
ASXC : 0.2868 (-1.10%)
Asensus Surgical (ASXC) Reports Q2 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 12.50% and 20.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ASXC : 0.2868 (-1.10%)
NVCN : 30.03 (+1.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Asensus Surgical Inc. is a medical device company which is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM). Asensus Surgical Inc., formerly known as TransEnterix Inc., is based in RESEARCH TRIANGLE PARK, N.C.

See More

Key Turning Points

3rd Resistance Point 0.3082
2nd Resistance Point 0.3011
1st Resistance Point 0.2955
Last Price 0.2868
1st Support Level 0.2828
2nd Support Level 0.2757
3rd Support Level 0.2701

See More

52-Week High 0.9564
Fibonacci 61.8% 0.6690
Fibonacci 50% 0.5802
Fibonacci 38.2% 0.4914
Last Price 0.2868
52-Week Low 0.2040

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar